CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Blood flow restriction (BFR)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04484961
NCT04484961N/ACompleted
CompareCT.gov

Effects of Blood Flow Restriction Rehabilitation After Bone Patellar Tendon Bone Anterior Cruciate Ligament Reconstruction

The Methodist Hospital Research Institute·interventional·Posted Jul 24, 2020·Updated Nov 25, 2024

In Brief

A clinical study evaluating Blood flow restriction (BFR) for ACL Tear. Completed, enrolled 50 participants.

Detailed Summary

The study is a prospective randomized control trial consisting of subjects requiring ACL reconstruction with BTB autograft. Subjects were randomly divided into two groups following their inclusion in the study. One group underwent the normal ACL rehab protocol as determined by the participating surgeons. The study group underwent normal ACL rehab modified by use of a tourniquet for blood flow restriction during selected exercises.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsACL Tear
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 24, 2020
Enrollment StartMar 18, 2016
Primary CompletionJul 10, 2020
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 5.9 years ago

Interventions

Blood flow restriction (BFR)device

The study group underwent normal ACL rehab modified by use of a tourniquet for blood flow restriction during selected exercises.